| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...730607G |
| P356 | DOI | 10.1371/JOURNAL.PONE.0030607 |
| P932 | PMC publication ID | 3266296 |
| P698 | PubMed publication ID | 22295096 |
| P5875 | ResearchGate publication ID | 221796266 |
| P50 | author | Julia di Iulio | Q56525311 |
| Silvana Gaudieri | Q89100814 | ||
| Andri Rauch | Q92034483 | ||
| David Martino | Q42716608 | ||
| P2093 | author name string | Susan L Prescott | |
| Michaela Lucas | |||
| Andrew Lucas | |||
| Elizabeth McKinnon | |||
| Meri K Tulic | |||
| Hiba Albloushi | |||
| P2860 | cites work | Differences in innate immune function between allergic and nonallergic children: New insights into immune ontogeny | Q51895264 |
| Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response. | Q53019296 | ||
| Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro. | Q54529235 | ||
| Role of deficient type III interferon-λ production in asthma exacerbations | Q57981862 | ||
| IL-28, IL-29 and their class II cytokine receptor IL-28R | Q24323830 | ||
| Genetic variation in IL28B and spontaneous clearance of hepatitis C virus | Q24596340 | ||
| Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity | Q24642027 | ||
| Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 | ||
| Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytes | Q28269054 | ||
| Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study | Q28269827 | ||
| Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells | Q28297426 | ||
| Longitudinal data analysis for discrete and continuous outcomes | Q29547235 | ||
| IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy | Q29614896 | ||
| Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys | Q29615415 | ||
| The natural history of hepatitis C virus infection: host, viral, and environmental factors | Q33974693 | ||
| IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. | Q34142463 | ||
| Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance | Q35083980 | ||
| Interferon-lambda as a new approach for treatment of allergic asthma? | Q36038749 | ||
| Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection | Q36725968 | ||
| Insights into the role of STAT3 in human lymphocyte differentiation as revealed by the hyper-IgE syndrome | Q37358407 | ||
| Epigenetics and prenatal influences on asthma and allergic airways disease | Q37848530 | ||
| Gene-environment interactions in chronic inflammatory disease | Q37855517 | ||
| IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease | Q41863615 | ||
| Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. | Q42996760 | ||
| Interferon-lambda serum levels in hepatitis C. | Q43031833 | ||
| A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice | Q43625075 | ||
| Presymptomatic differences in Toll-like receptor function in infants who have allergy. | Q46525347 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e30607 | |
| P577 | publication date | 2012-01-25 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Genetic variations in IL28B and allergic disease in children | |
| P478 | volume | 7 |
| Q41621173 | A functional IFN-λ4-generating DNA polymorphism could protect older asthmatic women from aeroallergen sensitization and associate with clinical features of asthma |
| Q34375569 | Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α-based regimens |
| Q37286645 | Developmental programming of growth: genetic variant in GH2 gene encoding placental growth hormone contributes to adult height determination |
| Q42987491 | From genetic association studies to the biology of interleukin-28B in hepatitis C virus infection and beyond |
| Q38859455 | Gene-disease association with human IFNL locus polymorphisms extends beyond hepatitis C virus infections. |
| Q37997043 | IFN-λ and IgE-mediated allergic disease: a potential future role? |
| Q47130188 | Immune Cell Profiling of IFN-λ Response Shows pDCs Express Highest Level of IFN-λR1 and Are Directly Responsive via the JAK-STAT Pathway. |
| Q38064651 | Interferon-λs: special immunomodulatory agents and potential therapeutic targets. |
| Q42983483 | One more piece in the interleukin 28B gene puzzle? The case of hepatitis B. |
| Q38337013 | The Role of Interferon-λ Locus Polymorphisms in Hepatitis C and Other Infectious Diseases. |
| Q36208380 | The impact of interferon lambda 3 gene polymorphism on natural course and treatment of hepatitis C |
| Q37997041 | The interferon family as biomarkers of disease: renaissance of the innate immune system |
Search more.